Celldex Therapeutics

Celldex laces up next to Big Pharma players as drug reduces severity of chronic hives
Fierce Biotech
Mon, 11/6/23 - 11:31 am
Celldex Therapeutics
clinical trials
monoclonal antibodies
barzolvolimab
chronic hives
Scratching the surface of the urticaria pipeline
EP Vantage
Thu, 07/20/23 - 10:00 am
chronic urticaria
Sanofi
Dupixent
Regeneron
Novartis
Roche
Xolair
Allakos
AstraZeneca
Celldex Therapeutics
Chronic hives: Four major clinical trials to watch in 2023
Clinical Trials Arena
Wed, 05/3/23 - 11:53 am
chronic hives
chronic urticaria
clinical trials
Sanofi
Regeneron
dupilumab
Amgen
tezepelumab
Allakos
lirentelimab
Celldex Therapeutics
barzolvolimab
Celldex pins its hopes for a comeback on skin disease drug
BioPharma Dive
Sun, 07/11/21 - 10:48 pm
Celldex Therapeutics
chronic urticaria
The Week Ahead In Biotech: ASCO Presentations In The Spotlight
Yahoo/Benzinga
Mon, 05/28/18 - 02:14 pm
ASCO 2018
European Society of Cardiology
TherapeuticsMD
Abiomed
Incyte
Bluebird Bio
Celgene
Syndax
Loxo Oncology
Exelixis
Karyopharm
Endocyte
Celldex Therapeutics
Jounce Therapeutics
Bristol-Myers Squibb
Nektar
Celldex brings out the ax in wake of breast cancer drug disaster, chopping a quarter of its staff
Endpoints
Wed, 04/25/18 - 09:40 am
Celldex Therapeutics
layoffs
Celldex's highly anticipated breast cancer drug fails to hit the mark in a midstage trial
Motley Fool
Mon, 04/16/18 - 09:10 am
Celldex Therapeutics
triple negative breast cancer
glemba
7 of the Most Shocking Biotech Pipeline Blowups of 2016
Motley Fool
Sun, 12/4/16 - 12:37 pm
biotech
Alnylam
revusiran
Clovis Oncology
rociletinib
Celldex Therapeutics
Rintega
Eli Lilly
solanezumab
Novavax
RSV-F
Arrowhead
ARC-520
ARC-521
ARC-AAT
Biomarin
drisapersen
Celldex Cancer Drug Shows Good Early Data
Investopedia
Wed, 11/16/16 - 09:49 am
Celldex Therapeutics
CDX-1140
lymphoma
Celldex Acquires Cancer Medicine Company for $62.5 Million
Yahoo
Thu, 11/3/16 - 09:44 am
Celldex Therapeutics
M&A
Kolton Pharmaceuticals
These 3 Little Biotechs Just Scored Big
Motley Fool
Tue, 10/11/16 - 09:33 pm
biotech
Celldex Therapeutics
melanoma
glemba
Exelixis
Cabometyx
renal cell carcinoma
Tesaro
ovarian cancer
niraparib
Key FDA Decisions and Trial Results Expected in October
24/7 Wall St
Tue, 10/4/16 - 10:07 am
FDA
clinical trials
Exelixis
cabozantinib
Cobimetinib
Celldex Therapeutics
CDX-011
Cerulean Pharma
CRLX101
Medivation
Xtandi
Palatin
bermelanotide
Rexahn
RX-3117
Anthera Pharmaceuticals
Key FDA Decisions and Trial Results Expected in October
24/7 Wall St
Thu, 09/8/16 - 09:50 am
FDA
clinical trials
cabozantinib
Cobimetinib
Exelixis
Medivation
Xtandi
Celldex Therapeutics
glemba
Palatin
bremelanotide
CRLX101
Cerulean Pharma
Anthera Pharmaceuticals
3 Shocking Biotech Flops of 2016 So Far
Motley Fool
Fri, 07/8/16 - 11:01 am
biotech
Rintega
Celldex Therapeutics
glioblastoma
Clovis Oncology
rociletinib
lung cancer
NewLink Genetics
algenpantucel-L
pancreatic cancer
4 Cancer Drug Developers You Need to Have on Your Radar This Year
Motley Fool
Wed, 06/15/16 - 10:33 am
cancer
Exelixis
Celldex Therapeutics
Ziopharm
Jazz Pharmaceuticals
Biotech's Top 5 Stock Winners, And Losers, In Q1 2016
Forbes
Thu, 03/31/16 - 09:49 pm
biotech
PTC Therapeutics
Celldex Therapeutics
Biocryst
Puma Biotechnology
Portola Pharmaceuticals
MedicNova
BioTie Therapies
Editas Medicine
AveXis
Inovio
Celldex Brain Tumor Vaccine Fails Pivotal Clinical Trial
TheStreet.com
Mon, 03/7/16 - 09:37 am
Celldex Therapeutics
clinical trials
Rintega
glioblastoma multiforme
3 Biotech Stocks With Jaw-Dropping Growth Potential in 2016
Motley Fool
Sun, 01/17/16 - 12:11 pm
biotech
Inovio
Celldex Therapeutics
Novavax
10 Worst NASDAQ Biotech Stocks in the Third Quarter
TheStreet.com
Wed, 09/30/15 - 07:51 pm
Orexigen
Immunomedics
Celldex Therapeutics
Arena Pharmaceuticals
Theravance
Karyopharm
Raptor Pharmaceutical
Verastem
Tetraphase
Xoma
3 Experimental Cancer Drugs Investors Should Be Closely Watching
Motley Fool
Fri, 07/3/15 - 11:20 am
cancer
JCAR015
Juno Therapeutics
Celgene
Celldex Therapeutics
Rentiga
Geron
imetelstat

Pages